標(biāo)題: Titlebook: Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy; F. M. Muggia Book 1987 Martinus Nijhoff Publishers, Bost [打印本頁(yè)] 作者: 存貨清單 時(shí)間: 2025-3-21 16:52
書(shū)目名稱(chēng)Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy影響因子(影響力)
書(shū)目名稱(chēng)Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy被引頻次
書(shū)目名稱(chēng)Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy被引頻次學(xué)科排名
書(shū)目名稱(chēng)Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy年度引用
書(shū)目名稱(chēng)Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy年度引用學(xué)科排名
書(shū)目名稱(chēng)Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy讀者反饋
書(shū)目名稱(chēng)Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy讀者反饋學(xué)科排名
作者: 燒烤 時(shí)間: 2025-3-22 00:02
Metabolites of tiazofurin as mediators of its biochemical and pharmacologic effectshe subcutaneous Lewis lung carcinoma, a transplantable tumor resistant to the vast majority of standard and experimental chemotherapeutic drugs. Moreover, cures were achieved over a broad range of doses of the compound [4]. It was these studies, then, that prompted the development of tiazofurin towa作者: 染色體 時(shí)間: 2025-3-22 03:33
Extragonadal and central nervous system germ cell tumors: A review of diagnostic and therapeutic strns used in primary testicular cancer. This review will attempt to provide a review of EGGCT’s including their origin, clinical syndromes, past therapeutic strategies, and further directions of treatment.作者: 哎呦 時(shí)間: 2025-3-22 05:06 作者: 勾引 時(shí)間: 2025-3-22 12:36 作者: 好色 時(shí)間: 2025-3-22 14:44 作者: 好色 時(shí)間: 2025-3-22 18:08
https://doi.org/10.1007/978-3-031-29336-8ns used in primary testicular cancer. This review will attempt to provide a review of EGGCT’s including their origin, clinical syndromes, past therapeutic strategies, and further directions of treatment.作者: gustation 時(shí)間: 2025-3-22 23:41
Tort and Regulatory Law in Polandduced by a variety of different cells including macrophages, null cells (non-B- and non-T-lymphocytes) and transformed B-cell lines, are a family of at least 14 species that share a 75% or greater amino acid sequence homology. Beta IFN, which shares .30% amino acid sequence homology with alpha IFNs,作者: 有害 時(shí)間: 2025-3-23 02:57 作者: 有雜色 時(shí)間: 2025-3-23 08:15
0927-3042 ion. First, by dividing the oncology literature into specific subdivisions such as lung can- cer, genitourinary cancer, pediatric oncology, etc. Second, by aski978-1-4612-9224-1978-1-4613-2061-6Series ISSN 0927-3042 Series E-ISSN 2509-8497 作者: 上流社會(huì) 時(shí)間: 2025-3-23 12:56
Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy作者: refine 時(shí)間: 2025-3-23 17:18 作者: fastness 時(shí)間: 2025-3-23 19:05
Tort and Regulatory Law in Norwayce, and the most familiar examples occur with the use of methotrexate (MTX), fluorodeoxyuridine (FdUrd), and cytosine arabinoside (ara-C). The general motivation for the study of schedule-dependence is to improve the therapeutic index of a drug, i.e., to maximize the ratio of therapeutic effects to toxic effects.作者: Opponent 時(shí)間: 2025-3-24 00:59 作者: 兩棲動(dòng)物 時(shí)間: 2025-3-24 04:55 作者: Angiogenesis 時(shí)間: 2025-3-24 09:09
Eckhardt. Peterson,Frank J. ErbguthThe majority of viruses are associated with acute limited diseases in healthy hosts. For this reason, the development of safe and effective antiviral agents has until recently been slow.作者: 使顯得不重要 時(shí)間: 2025-3-24 14:33 作者: 舊石器時(shí)代 時(shí)間: 2025-3-24 18:06
Role of preclinical pharmacology in phase I clinical trials: Considerations of schedule-dependencece, and the most familiar examples occur with the use of methotrexate (MTX), fluorodeoxyuridine (FdUrd), and cytosine arabinoside (ara-C). The general motivation for the study of schedule-dependence is to improve the therapeutic index of a drug, i.e., to maximize the ratio of therapeutic effects to toxic effects.作者: gain631 時(shí)間: 2025-3-24 22:04 作者: Pituitary-Gland 時(shí)間: 2025-3-25 02:24
The View from Law and Economicsent modelling studies, suggesting a pharmacokinetic rationale for this method of drug delivery to tumors principally confined to the peritoneal cavity, has renewed interest in this idea [3]. In this review the basic principles of intraperitoneal chemotherapy will be presented along with a discussion作者: Ambiguous 時(shí)間: 2025-3-25 07:04
,《EC Tort Law》 and the German legal family,ounds [1,2]. In fact, the agent does exhibit a modest to moderate degree of activity against several pathogenic viruses [2,3]. However, at the time, this activity apparently was not judged sufficient to warrant development of the drug towards clinical trials. With the advent of managerial changes at作者: Galactogogue 時(shí)間: 2025-3-25 07:28 作者: 阻止 時(shí)間: 2025-3-25 15:24
Tort and Regulatory Law in Norwayce, and the most familiar examples occur with the use of methotrexate (MTX), fluorodeoxyuridine (FdUrd), and cytosine arabinoside (ara-C). The general motivation for the study of schedule-dependence is to improve the therapeutic index of a drug, i.e., to maximize the ratio of therapeutic effects to 作者: 混沌 時(shí)間: 2025-3-25 18:32
Tort and Regulatory Law in Polandained a substance capable of preventing the growth of active virus. This substance, named interferon (IFN), was later shown to be composed of a system of structurally related proteins that act directly on the target cells, not on the virus, and are produced by many types of animal cells in response 作者: 否決 時(shí)間: 2025-3-25 21:55 作者: Wordlist 時(shí)間: 2025-3-26 02:00
https://doi.org/10.1007/978-3-642-56828-2hwannomas which carried a high surgical mortality rate in Cushing’s era are now removed safely and successfully as are pituitary tumors and most meningiomas. The impact of these technical advances on the management of the malignant intracranial tumors, in particular on the glioblastoma multiforme, t作者: ETCH 時(shí)間: 2025-3-26 07:52 作者: 致命 時(shí)間: 2025-3-26 11:10 作者: Morphine 時(shí)間: 2025-3-26 12:42 作者: 郊外 時(shí)間: 2025-3-26 16:47
Intraperitoneal chemotherapy: Principles and results of clinical trials of the theoretical and practical problems associated with the technique. Finally, a summary of recent single agent and combination intraperitoneal chemotherapy trials will be presented as well as a brief discussion of other innovative approaches utilizing the intraperitoneal route.作者: 明智的人 時(shí)間: 2025-3-26 23:04
Acivicin: A new antimetaboliteg toxicity of acivicin. This review will cover some of the experimental background of current clinical research involving acivicin, will relate clinical findings to the preclinical pharmacology of the drug, and will suggest some new directions for both clinical and preclinical research.作者: Parallel 時(shí)間: 2025-3-27 04:10
The clinical horizon of deoxycoformycinibitor of aspartate transcarbamylase. Pyrazofurin inhibits orotidylate synthetase irreversibly; both arrest de novo pyrimidine biosynthesis and are cytotoxic to several tumor models in vitro and in vivo. However, in extensive phase II clinical testing by the NCI in the past ten years, neither showed any reproducible activity.作者: 不透明 時(shí)間: 2025-3-27 09:08
The View from Law and Economics of the theoretical and practical problems associated with the technique. Finally, a summary of recent single agent and combination intraperitoneal chemotherapy trials will be presented as well as a brief discussion of other innovative approaches utilizing the intraperitoneal route.作者: figurine 時(shí)間: 2025-3-27 12:10 作者: GUILT 時(shí)間: 2025-3-27 17:16 作者: Exonerate 時(shí)間: 2025-3-27 18:03 作者: 貞潔 時(shí)間: 2025-3-28 01:17 作者: 印第安人 時(shí)間: 2025-3-28 02:48 作者: MIR 時(shí)間: 2025-3-28 07:52 作者: ALOFT 時(shí)間: 2025-3-28 13:31 作者: 易怒 時(shí)間: 2025-3-28 16:08
Metabolites of tiazofurin as mediators of its biochemical and pharmacologic effectsounds [1,2]. In fact, the agent does exhibit a modest to moderate degree of activity against several pathogenic viruses [2,3]. However, at the time, this activity apparently was not judged sufficient to warrant development of the drug towards clinical trials. With the advent of managerial changes at作者: 胖人手藝好 時(shí)間: 2025-3-28 22:27
Extragonadal and central nervous system germ cell tumors: A review of diagnostic and therapeutic strpproximately 2.1 to 3.1 cases per 100,000 males in the United States and Great Britain [1]. Amongst those cases of germ cell tumors about 1% to 2% have an extragonadal origin. These tumors possess a similar spectrum of pathologies as their primary testicular counterparts [2–6] and include all types 作者: intertwine 時(shí)間: 2025-3-29 02:08
Role of preclinical pharmacology in phase I clinical trials: Considerations of schedule-dependencece, and the most familiar examples occur with the use of methotrexate (MTX), fluorodeoxyuridine (FdUrd), and cytosine arabinoside (ara-C). The general motivation for the study of schedule-dependence is to improve the therapeutic index of a drug, i.e., to maximize the ratio of therapeutic effects to 作者: ear-canal 時(shí)間: 2025-3-29 03:34 作者: MUMP 時(shí)間: 2025-3-29 08:57 作者: IRATE 時(shí)間: 2025-3-29 13:01
Chemotherapy for malignant intracranial tumorshwannomas which carried a high surgical mortality rate in Cushing’s era are now removed safely and successfully as are pituitary tumors and most meningiomas. The impact of these technical advances on the management of the malignant intracranial tumors, in particular on the glioblastoma multiforme, t
